Results 131 to 140 of about 112,978 (213)

Development of Sub‐50 nm Core–Shell Silica Nanoparticles With Controlled In Vivo Behavior for 19F Magnetic Resonance Imaging

Angewandte Chemie, EarlyView.
Ultrasmall PFCE‐loaded silica nanoparticles synthesized through a one‐pot double‐emulsion synthesis method, where rapid silica shell formation kinetically fixes droplet size. The resulting s‐FLAME nanoparticles enable strong 19F MRI signals with enhanced hepatic clearance rate and tumor‐accumulation performance. ABSTRACT 19F magnetic resonance imaging (
Yue Wu, Masafumi Minoshima, Kazuya Kikuchi   +2 more
wiley   +2 more sources

Population pharmacokinetics and safety of continuous oxacillin in preterm and term neonates and infants. [PDF]

Antimicrob Agents Chemother
Lee A, Liu C, Tran MT, Phal S, Peloquin CA, Nieves D, Capparelli E, Arrieta AC.   +7 more
europepmc   +1 more source

A Randomized Phase II Study of Subcutaneous Mosunetuzumab in Combination With Polatuzumab Vedotin Compared With Rituximab Plus Polatuzumab Vedotin in Patients With Relapsed or Refractory Large B‐Cell Lymphoma

American Journal of Hematology, EarlyView.
ABSTRACT Mosunetuzumab plus polatuzumab vedotin has shown promising activity versus rituximab plus polatuzumab vedotin (R‐Pola) in patients with relapsed/refractory (R/R) large B‐cell lymphoma (LBCL; NCT03671018). We present results from the Phase II randomized cohort, evaluating subcutaneous mosunetuzumab plus polatuzumab vedotin (Mosun‐Pola), with ...
Julio C. Chavez, Mariana Bastos‐Oreiro, Catherine Diefenbach, Izidore S. Lossos, Nirav Shah, Sarit Assouline, Adam J. Olszewski, Seema Naik, Nilanjan Ghosh, Song Pham, Michael C. Wei, Connie Batlevi, Iris To, Wahib Ead, Sneha Makadia, Elicia Penuel, Jing Jing, Lihua E. Budde   +17 more
wiley   +1 more source

Mitochondria‐Damaging Self‐Reporting Probe for Cancer Therapy

Angewandte Chemie, EarlyView.
We developed a class of self‐reporting cationic chemotherapeutic probes that selectively induce mitochondrial damage and apoptosis in cancer cells. Their unique mitochondria‐to‐nucleus fluorescence migration enables real‐time visualization of the therapeutic process. ABSTRACT Mitochondrial damage induced by chemotherapeutic agents through disruption of
Hai Xu, Yura Lee, Sanghee Yoon, Yun Wang, Yejin Cho, Seongyu Choi, Lu Lu, Hua Zhang, Sun Choi, Ki Taek Nam, Juyoung Yoon   +10 more
wiley   +2 more sources

Population Pharmacokinetics of Sildenafil in Dogs With Naturally Occurring Pulmonary Hypertension. [PDF]

J Vet Pharmacol Ther
Yata M, DeFrancesco TC, Bonagura JD, Papich MG.   +3 more
europepmc   +1 more source

Animal research in the UK: Regulation, implementation, welfare and development of new approach methodologies

Animal Models and Experimental Medicine, EarlyView.
Scientific research with animals in the UK is regulated by the Animals (Scientific Procedures) Act 1986 with the National Centre for the Replacement, Refinement and Reduction of Animals in Research providing support for best practice and facilitating development of new approach methodologies.
Ewan St. John Smith, James Bussell, Maggie Gentry, Elliot Lilley, Cathy Merry, Judy MacArthur Clark, William Reynolds   +6 more
wiley   +1 more source

Mechanically Regulated Nanozymes for Remote Metabolic Reprogramming and Precise Cancer Therapy

Angewandte Chemie, EarlyView.
Inspired by mechanoenzymes, a ferrocene‐based mechanically regulated nanozyme converts acoustic shear force into enhanced peroxidase‐like activity by decreasing electron density and alleviating steric hindrance at the Fe active sites, thereby rewiring redox homeostasis. Leveraging this remote regulatory mechanism, a multienzyme‐regulated nanoreactor is
Fangman Chen, Xiaochun Xie, Hanyao Huang, Ka Hong Wong, Jiying Liu, Hui Fang, Shaowen Wang, Jianfang Cao, Yu Tao, Mingqiang Li, Chao Yang, Wen Sun, Dan Shao, Yunlu Dai   +13 more
wiley   +2 more sources

Population pharmacokinetics of tofacitinib in patients with active ankylosing spondylitis. [PDF]

Int J Clin Pharmacol Ther
Tsuchiwata S, Suzuki A, Wang Q, Kanik K, Fallon L, Menon S.   +5 more
europepmc   +1 more source

Liposomal Delivery of L‐2‐Hydroxyglutarate for Targeting Epigenetic Dysregulation in Osteoarthritis

Advanced NanoBiomed Research, EarlyView.
Osteoarthritis involves cartilage degeneration, inflammation, and epigenetic dysregulation. A liposomal formulation of the TET1 inhibitor L‐2‐hydroxyglutarate to overcome rapid joint clearance was developed. The formulation showed good physicochemical properties, reduced inflammatory and catabolic gene expression in chondrocytes, and alleviated ...
Denise Murgia, Akshay Pandey, Raffaele Spanò, Bianca Martins Estevão, Roberto Palomba, Greta Avancini, Tamaghna Gupta, Ana Maria Lopez Estevez, Stuart B. Goodman, Nidhi Bhutani, Paolo Decuzzi   +10 more
wiley   +1 more source

Stochastic Gates for Covariate Selection in Population Pharmacokinetics Modeling. [PDF]

CPT Pharmacometrics Syst Pharmacol
Kekic M, Stepanov O, Wang W, Richardson S, Olabode D, Traynor C, Dearden R, Zhou D, Tang W, Gibbs M, Nowojewski A.   +10 more
europepmc   +1 more source